PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-29
DOI
10.1038/s41375-019-0556-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
- (2018) Michael Hallek et al. BLOOD
- Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy
- (2018) Jan A. Burger et al. Nature Reviews Clinical Oncology
- Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas
- (2018) Natalia Saenz-Ponce et al. Science Translational Medicine
- Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages
- (2018) Evangelia Goulielmaki et al. Cell Death & Disease
- Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)
- (2018) Shlomo Elias et al. OncoImmunology
- Small GTPase Rab8a-recruited Phosphatidylinositol 3-Kinase γ Regulates Signaling and Cytokine Outputs from Endosomal Toll-like Receptors
- (2017) Adam A. Wall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reprogramming Nurse-like Cells with Interferon γ to Interrupt Chronic Lymphocytic Leukemia Cell Survival
- (2016) Shalini Gautam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients
- (2016) M Burgess et al. ONCOGENE
- Nurse-like cells impact on disease progression in chronic lymphocytic leukemia
- (2016) F Boissard et al. Blood Cancer Journal
- Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression
- (2016) Giovanni Galletti et al. Cell Reports
- Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
- (2015) Ali Roghanian et al. CANCER CELL
- Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages
- (2015) A. K. Church et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- RP105 Engages Phosphatidylinositol 3-Kinase p110δ To Facilitate the Trafficking and Secretion of Cytokines in Macrophages during Mycobacterial Infection
- (2015) Chien-Hsiung Yu et al. JOURNAL OF IMMUNOLOGY
- Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo
- (2015) B S Hanna et al. LEUKEMIA
- Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target
- (2015) Fortunato Morabito et al. LEUKEMIA & LYMPHOMA
- Glycoengineering of Therapeutic Antibodies Enhances Monocyte/Macrophage-Mediated Phagocytosis and Cytotoxicity
- (2014) S. Herter et al. JOURNAL OF IMMUNOLOGY
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Advanced Leukemic Stage and Skin Cancer Tumor Stage With Poor Skin Cancer Outcomes in Patients With Chronic Lymphocytic Leukemia
- (2014) Nicole F. Velez et al. JAMA Dermatology
- The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer
- (2014) Ross Stewart et al. Journal for ImmunoTherapy of Cancer
- Skin Cancer Surveillance and Malignancies of the Skin in a Community-Dwelling Cohort of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
- (2014) Aaron S. Mansfield et al. Journal of Oncology Practice
- CD62L as a Therapeutic Target in Chronic Lymphocytic Leukemia
- (2013) M. Burgess et al. CLINICAL CANCER RESEARCH
- PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances
- (2012) Lomon So et al. BIOCHEMICAL JOURNAL
- Phosphoinositide 3-kinase δ regulates membrane fission of Golgi carriers for selective cytokine secretion
- (2010) Pei Ching Low et al. JOURNAL OF CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search